Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Walker

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.
Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.
Human Gene Therapy|August 20, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 28, 1999
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 1, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|February 4, 1998
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|April 25, 2000
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Antimicrobial Agents and Chemotherapy|July 1, 1996
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patientsR T Davey, D G Chaitt, G F Reed, et al.
JAMA|November 30, 1999
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitisS M Whitcup, E Fortin, A S Lindblad, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 1999
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppressionR T Davey, N Bhat, C Yoder, et al.
Blood|July 11, 2000
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infectionR E Walker, C M Bechtel, V Natarajan, et al.
Human Gene Therapy|August 20, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 28, 1999
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|December 1, 1996
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|February 4, 1998
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Human Gene Therapy|April 25, 2000
Human gene marker/therapy clinical protocolsS A Rosenberg, R M Blaese, M K Brenner, et al.
Pageof 9